8-K - Opus Genetics, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Opus Genetics, Inc. (IRD) filed a Form 8-K on March 10, 2026, under Item 2.02 with Exhibit 99.1 press release furnished, announcing results of operations. The filing includes historical analyst consensus EPS data and forward consensus estimates for 2027.

Key Takeaways

1Filing under Item 2.02 Results of Operations and Item 9.01 Exhibits

2Exhibit 99.1: Press Release dated 2026-03-10

32025-11-12 EPS $-0.12 vs est $-0.14

42025-08-13 EPS $-0.12 vs est $-0.25

52025-05-15 EPS $-0.32 vs est $-0.34

6Forward 2027-03-31 consensus EPS $-0.13

7Forward 2027-06-30 consensus EPS $-0.13

Current Report Details

Event Type

Financial Results

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

of this Current Report on Form 8-K, and Exhibit 99.1, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of

Financial Results

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated March 10, 2026. 104.1 Cover Page Interactive Data File (embedd

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EXHIBIT 99.1